Seqens Seqens

X

Find Radio Compass News for Nalbuphine Hydrochloride

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-upcoming-april-events-302107936.html

PR NEWSWIRE
04 Apr 2024

https://www.prnewswire.com/news-releases/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team-302104511.html

PR NEWSWIRE
02 Apr 2024

https://www.biospace.com/article/releases/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team/

BIOSPACE
02 Apr 2024

https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-first-quarter-2023-financial-results-and-provides-business-update-301822566.html

PR NEWSWIRE
11 May 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

FDA
22 Feb 2023

https://www.clinicaltrialsarena.com/news/trevi-haduvio-idf-trial/

CLINICALTRIALSARENA
19 Sep 2022

https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-multiple-late-breaking-abstracts-accepted-for-presentation-at-upcoming-medical-conferences-on-analysis-of-oral-nalbuphine-extended-release-301611299.html

PRNEWSWIRE
24 Aug 2022

https://www.prnewswire.com/news-releases/trevi-therapeutics-completes-enrollment-for-phase-2b3-prism-study-in-chronic-pruritus-in-pn-301472377.html

PRNEWSWIRE
01 Feb 2022

https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-third-quarter-2021-financial-results-and-business-update-301421468.html

PRNEWSWIRE
10 Nov 2021

https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-11-8-million-private-placement-priced-at-the-market-301389411.html

PRNEWSWIRE
30 Sep 2021

https://www.globenewswire.com/news-release/2020/06/30/2055848/0/en/Trevi-Therapeutics-Announces-Election-of-Dominick-C-Colangelo-to-Board-of-Directors.html

GLOBENEWSWIRE
30 Jun 2020

https://www.prnewswire.com/news-releases/lumosa-announces-fda-acceptance-of-ind-application-for-lt1001-an-extended-release-analgesic-injection---lumosa-to-initiate-the-bridging-study-in-the-us-300968045.html

PR NEWSWIRE
03 Dec 2019

https://www.pharmacompass.com/pdf/news/Spectrum-Laboratory-Products-Receives-FDA-Warning-Letter-1560408618.pdf

FDA
04 Jun 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206506

FDA
08 Feb 2019

https://www.businesswire.com/news/home/20190204005046/en

BUSINESSWIRE
04 Feb 2019

https://www.businesswire.com/news/home/20180927005403/en

BUSINESSWIRE
27 Sep 2018

http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30

Eric Palmer FIERCE PHARMA MANUFACTURING
30 Apr 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY